arrow
M

Michel M. van den Heuvel

radboud university nijmegen
H指数:48
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

一种可扩展的深度学习框架,用于通过游离细胞DNA浅层全基因组测序进行癌症检测

2026-07-100
OA
Model-Informed Approaches to Develop Drug Cost-Saving Dosing Strategies for Pembrolizumab

基于模型的方法开发帕博利珠单抗的药物成本节约给药策略

2026-05-230
OAAI
Fatigue in COPD: a Longitudinal, Multidimensional Perspective

COPD中的疲劳:纵向、多维视角

2026-01-010
PRE
Serological Response Patterns to Assess Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Multi-Center Observational Cohort Study

血清学反应模式在评估晚期非小细胞肺癌治疗效果中的应用:一项真实世界探索性多中心观察性队列研究

2025-11-180
OAAI
Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicity

通过GSTM1基因分型优化lazertinib疗法:一种减少过量药物暴露和潜在毒性的策略

2025-11-070
OAAI
DuTOC: The prospective Dutch Thoracic Oncology Cohort: A nationwide infrastructure to collect clinical data, PROMS and bio-material to support thoracic oncology studies

DuTOC:荷兰胸癌前瞻性队列研究:一个全国性的基础设施,用于收集临床数据、患者报告结局测量(PROMs)和生物材料,以支持胸癌研究

2025-08-260
OAAI
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic–Pharmacoeconomic Evaluation

基于治疗药物监测的度鲁特玛在肺癌患者中的个体化给药:一项全面的群体药代动力学–药效经济学评估

2025-07-250
OAAI
Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer

帕博利珠单抗联合放疗在免疫冷型非小细胞肺癌中诱导系统性抗肿瘤免疫应答

2025-07-220
OA
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib

循环肿瘤DNA在晚期EGFRex20+ NSCLC中的研究:与组织活检的一致性、疗效监测及对高剂量奥希替尼耐药性的分析

2025-06-050
OAAI
Reply to Letter to the Editor “Lung cancer detection by electronic nose analysis of exhaled breath: a multi-center prospective external validation study” by Liu et al., G. Rocco, and Szarpak et al.

回复致编辑函“通过电子鼻分析呼出气检测肺癌:一项多中心前瞻性外部验证研究”由Liu等人、G. Rocco和Szarpak等人撰写。

2025-06-020
PRE